Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ester J. M. Siemerink"'
Publikováno v:
Clinical oncology, 34(6), 355-362. W.B. Saunders Ltd
Aims To analyse the disease-free survival and overall survival in older adults with breast cancer after breast-conserving therapy, focusing on the relevance of non-breast malignancy (NBM) with respect to survival rates. Materials and methods Analyses
Autor:
Lian Beenhakker, Annemieke Witteveen, Kim A. E. Wijlens, Ester J. M. Siemerink, Marije L. van der Lee, Christina Bode, Sabine Siesling, Miriam M. R. Vollenbroek‐Hutten
Publikováno v:
European journal of cancer care. 31(6)
Introduction Cancer-related fatigue (CRF) is one of the most reported long-term effects breast cancer patients experience after diagnosis. Many interventions for CRF are effective, however, not for every individual. Therefore, intervention advice sho
Autor:
Anouk H, Eijkelboom, Linda, de Munck, C Willemien, Menke-van der Houven van Oordt, Mireille J M, Broeders, Desiree H J G, van den Bongard, Luc J A, Strobbe, Marc A M, Mureau, Marc B I, Lobbes, Pieter J, Westenend, Linetta B, Koppert, Agnes, Jager, Ester J M, Siemerink, Jelle, Wesseling, Helena M, Verkooijen, Marie-Jeanne T F D, Vrancken Peeters, Marjolein L, Smidt, Vivianne C G, Tjan-Heijnen, Sabine, Siesling, I D, Nagtegaal
Publikováno v:
Breast cancer research and treatment. 197(1)
We aimed to compare (1) treatments and time intervals between treatments of breast cancer patients diagnosed during and before the COVID-19 pandemic, and (2) the number of treatments started during and before the pandemic.Women were selected from the
Publikováno v:
Strahlentherapie und Onkologie, 198(3). Urban und Vogel
Purpose: To investigate the effect of the timing of radiation therapy after breast-conserving surgery in relation to distant metastasis-free survival and disease-specific survival. Methods: The analysis was performed in relation to 4189 women all und
Autor:
Sabine Siesling, Christina Bode, Ester J. M. Siemerink, Roos Geertruida Maria Wolbers, Marcel E. Pieterse
Publikováno v:
Cancer Research. 80:P1-17
Objective: More than 50% of all breast cancer patients experience fatigue symptoms during and after their treatment course. Recent evidence shows that fatigue is partly driven by cognitive biases, such as the self-as-fatigued identity bias, which may
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 198(3)
To investigate the effect of the timing of radiation therapy after breast-conserving surgery in relation to distant metastasis-free survival and disease-specific survival.The analysis was performed in relation to 4189 women all undergoing breast-cons
Publikováno v:
Breast cancer research and treatment, 181(1), 13-21. Springer
Purpose: The aim of this study is to evaluate the prognostic value of the Mitotic Activity Index (MAI) in combination with the human epidermal growth factor receptor (Her2) for distant metastases-free survival (DMFS) and disease-specific survival (DS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99549aad1f073a578a05369af89a19a6
https://research.utwente.nl/en/publications/cd5cb5d2-5c57-4c6d-9fb0-5198b6bb8b32
https://research.utwente.nl/en/publications/cd5cb5d2-5c57-4c6d-9fb0-5198b6bb8b32
Autor:
Roos Geertruida Maria Wolbers, Sabine Siesling, Christina Bode, Marcel E. Pieterse, Ester J. M. Siemerink
Publikováno v:
JMIR Formative Research
JMIR Formative Research, Vol 5, Iss 3, p e18325 (2021)
JMIR Formative Research, 5(3):e18325. JMIR Publications
JMIR Formative Research, Vol 5, Iss 3, p e18325 (2021)
JMIR Formative Research, 5(3):e18325. JMIR Publications
Background More than 50% of all patients with breast cancer experience fatigue symptoms during and after their treatment course. Recent evidence has shown that fatigue is partly driven by cognitive biases such as the self-as-fatigued identity bias, w
Autor:
Linda M, Henricks, Ester J M, Siemerink, Hilde, Rosing, Judith, Meijer, Susan M I, Goorden, Abeltje M, Polstra, Lida, Zoetekouw, Annemieke, Cats, Jan H M, Schellens, André B P, van Kuilenburg
Publikováno v:
International Journal of Cancer. 142(2):424-430
Fluoropyrimidines are frequently used anti-cancer drugs. It is known that patients with reduced activity of dihydropyrimidine dehydrogenase (DPD), the key metabolic enzyme in fluoropyrimidine inactivation, are at increased risk of developing severe f
Autor:
André B.P. van Kuilenburg, Abeltje M. Polstra, Lida Zoetekouw, Jan H.M. Schellens, Annemieke Cats, Hilde Rosing, Judith Meijer, Ester J. M. Siemerink, Susan M. I. Goorden, Linda M. Henricks
Publikováno v:
International Journal of Cancer. 142:424-430
Fluoropyrimidines are frequently used anti-cancer drugs. It is known that patients with reduced activity of dihydropyrimidine dehydrogenase (DPD), the key metabolic enzyme in fluoropyrimidine inactivation, are at increased risk of developing severe f